Acrivon Therapeutics, Inc.

Acrivon Therapeutics, Inc. financial statements

Acrivon Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 77.91M10-K
Cash and equivalentsUSD 41.5M10-Q
Total debtUSD 2.71MEODHD

Acrivon Therapeutics, Inc. financials on 6ix · Acrivon Therapeutics, Inc. on 6ix